Search Result "PAF antagonists"
Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 6 Issue: 2 Year: 2006 Page: 129-133
Author(s): Lisa A. Teather
Platelet-Activating Factor (PAF): A Review of its Role in Asthma and Clinical Efficacy of PAF Antagonists in the Disease Therapy
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 2 Issue: 1 Year: 2008 Page: 72-76
Author(s): Alicja Kasperska-Zajac, Zenon Brzoza, Barbara Rogala
PAF Receptor and Tumor Growth
Journal: Current Drug Targets
Volume: 15 Issue: 10 Year: 2014 Page: 982-987
Author(s): Sonia Jancar,Roger Chammas
The Implication of Platelet Activating Factor in Cancer Growth and Metastasis: Potent Beneficial Role of PAF-Inhibitors and Antioxidants
Journal: Infectious Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 390-399
Author(s): A. B. Tsoupras, C. Iatrou, C. Frangia, C. A. Demopoulos
The Roles of Platelet-Activating Factor (PAF) and its Related Signaling and Metabolism in Neurological Diseases
Ebook: Molecular Aspects of Neurodegeneration and Neuroprotection
Volume: 1 Year: 2011
Author(s): Yutaka Hirashima
Doi: 10.2174/978160805092511101010090
Molecular Modelling Simulations and Inhibitory Effects of Naturally DerivedFlavonoids Targeting Platelet-Activating Factor Receptor (PAFR)
Journal: Letters in Drug Design & Discovery
Volume: 19 Issue: 1 Year: 2022 Page: 20-30
Author(s): Noraziah Nordin,Juriyati Jalil,Mohd Faiz Abd Ghani,Adib Afandi Abdullah,Rozana Othman
Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8 Issue: 3 Year: 2009 Page: 182-190
Author(s): Laura J. Edwards, Cris S. Constantinescu
Small Molecule Antagonists of Integrin Receptors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2371-2392
Author(s): A. Perdih, M. Sollner Dolenc
Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 1 Issue: 1 Year: 2003 Page: 1-11
Author(s): Steven M. Seiler, Michael S. Bernatowicz
Development and Potential Utility of Dual and Triple NK Receptor Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 3 Issue: 1 Year: 2003 Page: 1410-1422
Author(s): Charles A. Rizzo, John C. Anthes, Michel R. Corboz, Richard W. Chapman, Neng-Yang Shih, Greg A. Reichard, Kwokei J. Ng, John A. Hey